Surmodics Inc
NASDAQ:SRDX
Surmodics Inc
NASDAQ:SRDX
Price:
32.49 USD
-5.96%
Market Closed
Updated:
May 4, 2024
Surmodics Inc
Cash from Financing Activities
|
Surmodics Inc
Cash from Financing Activities Peer Comparison
Comparables:
BDX
BSX
SYK
ABT
ISRG
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Surmodics Inc
NASDAQ:SRDX
|
Cash from Financing Activities
-$1.4m
|
CAGR 3-Years
-14%
|
CAGR 5-Years
37%
|
CAGR 10-Years
26%
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Cash from Financing Activities
-$2.3B
|
CAGR 3-Years
-144%
|
CAGR 5-Years
4%
|
CAGR 10-Years
-10%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Cash from Financing Activities
$5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-73%
|
CAGR 10-Years
N/A
|
|
|
Stryker Corp
NYSE:SYK
|
Cash from Financing Activities
-$1.5B
|
CAGR 3-Years
-73%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
-25%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Cash from Financing Activities
-$7.1B
|
CAGR 3-Years
-33%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-9%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Cash from Financing Activities
$46.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-13%
|
CAGR 10-Years
N/A
|
See Also
What is Surmodics Inc's Cash from Financing Activities?
Cash from Financing Activities
-1.4m
USD
-1.4m
USD
Based on the financial report for Dec 31, 2023, Surmodics Inc's Cash from Financing Activities amounts to -1.4m USD.
What is Surmodics Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
26%
26%
The average annual Cash from Financing Activities growth rates for Surmodics Inc have been -14% over the past three years , 37% over the past five years , and 26% over the past ten years .
You don't have any saved screeners yet
